Viewing StudyNCT06409936

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06409936
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2024-05-07
Brief Title: PEARL Study PotEntial of Asciminib in the eaRly Treatment of CML
Sponsor: Gruppo Italiano Malattie EMatologiche dellAdulto
Organization: Gruppo Italiano Malattie EMatologiche dellAdulto
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Chronic Myeloid Leukemia
CML Chronic Phase
Chronic Myeloid Leukemia Chronic Phase
Chronic Myeloid Leukemia BCRABL-Positive
Keywords:
Name View
nilotinib View
asciminib View